Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib Plus S-1 in Advanced Gastric Cancer
NCT04338438Phase 2Completed
- Sponsor
- Beijing Friendship Hospital
- Start
- May 2015
- Primary completion
- Apr 2019
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Rivoceranib in gastric cancer (GC), sponsored by Beijing Friendship Hospital. Started May 2015; status: completed.
02
Drugs
Rivoceranib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04338438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04338438.